0001104659-24-003078.txt : 20240110 0001104659-24-003078.hdr.sgml : 20240110 20240110200041 ACCESSION NUMBER: 0001104659-24-003078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240108 FILED AS OF DATE: 20240110 DATE AS OF CHANGE: 20240110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bastone Bronwen CENTRAL INDEX KEY: 0001927636 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40949 FILM NUMBER: 24527731 MAIL ADDRESS: STREET 1: C/O ENFUSION, INC. STREET 2: 125 SOUTH CLARK STREET SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enfusion, Inc. CENTRAL INDEX KEY: 0001868912 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SOUTH CLARK STREET, SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 BUSINESS PHONE: (312) 253-9800 MAIL ADDRESS: STREET 1: 125 SOUTH CLARK STREET, SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 4 1 tm243083-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-08 0 0001868912 Enfusion, Inc. ENFN 0001927636 Bastone Bronwen C/O ENFUSION, INC. 125 SOUTH CLARK STREET SUITE 750 CHICAGO IL 60603 0 1 0 0 Chief People Officer 0 Class A Common Stock 2024-01-08 4 S 0 391 9.23 D 154256 D Class A Common Stock 2024-01-09 4 S 0 410 8.95 D 153846 D Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares, and does not represent discretionary trades by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.17 to $9.34. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.82 to $9.11. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request. /s/ Matthew Campobasso, as Attorney-in-Fact 2024-01-10